Saudi Food and Drug Authority (SFDA) has issued Version 1.0 of new
RegulinkedSFDA has issued Version 2.0 of the “Guidance for Combination Products Classification
RegulinkedSFDA has issued Version 9.0 of the “Products Classification Guidance”, introducing updated
RegulinkedSFDA issued the updated “Clinical Considerations for Vaccines” guideline – Version 2.0
RegulinkedThe Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of
RegulinkedSFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
RegulinkedSFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
RegulinkedThe Saudi Food & Drug Authority (“SFDA”) has issued a new guidance
RegulinkedSFDA issues “Good Review Practices (GRevPs)” Guideline Version 1.0 🔍 What’s new:
RegulinkedSFDA publishes Version 4.0 of Data Requirements for Human Drug Submissions (August
Regulinked
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.